Search hospitals

>

Kansas

>

Mission

University of Kansas Hospital-Westwood Cancer Center

Claim this profile

Mission, Kansas 66205

Global Leader in Cancer

Global Leader in Breast Cancer

Conducts research for Lung Cancer

Conducts research for Pancreatic Cancer

Conducts research for Non-Small Cell Lung Cancer

343 reported clinical trials

43 medical researchers

Photo of University of Kansas Hospital-Westwood Cancer Center in MissionPhoto of University of Kansas Hospital-Westwood Cancer Center in Mission

Summary

University of Kansas Hospital-Westwood Cancer Center is a medical facility located in Mission, Kansas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer and other specialties. University of Kansas Hospital-Westwood Cancer Center is involved with conducting 343 clinical trials across 469 conditions. There are 43 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.

Area of expertise

1

Cancer

Global Leader

University of Kansas Hospital-Westwood Cancer Center has run 60 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
p16 positive
2

Breast Cancer

Global Leader

University of Kansas Hospital-Westwood Cancer Center has run 59 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at University of Kansas Hospital-Westwood Cancer Center

Breast Cancer

Lung Cancer

Skin Cancer

Prostate Cancer

Cancer

Breast cancer

Pancreatic Cancer

Non-Small Cell Lung Cancer

Non-Hodgkin's Lymphoma

Small Cell Lung Cancer

Image of trial facility.

Ribociclib + Hormone Therapy

for Breast Cancer

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).

Recruiting

2 awards

Phase 3

4 criteria

Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.

Recruiting

2 awards

Phase 3

15 criteria

Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.

Recruiting

2 awards

Phase 3

19 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Kansas Hospital-Westwood Cancer Center?

Where is University of Kansas Hospital-Westwood Cancer Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Kansas Hospital-Westwood Cancer Center accept?

What awards or recognition has University of Kansas Hospital-Westwood Cancer Center received?